Sign inJoin waitlistJoin the waitlist

GN

Garrett Nash

Vice President of Quality and Safety · New York Presbyterian Hospital

Credentials: · · · · · ·

History

Quality and Safety · New York Presbyterian Hospital
Present

Cornell Univ Joan and Sanford I Weill Med Coll
2005–2006
Memorial Sloan Kettering Cancer Center
2004–2005
NewYork-Presbyterian
1999–2004
Colon and Rectal Surgery
NewYork-Presbyterian
1998–1999
Harvard T.H. Chan School of Public Health
Columbia University Vagelos College of Physicians and Surgeons
1994–1998

Research

Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy
Journal of Clinical Oncology · 2022 · 795 citations
Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
JAMA Oncology · 2018 · 511 citations
Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy
JAMA Oncology · 2019 · 464 citations

Philip Paty
121 papers
MW
Martin Weiser
115 papers
JG
Julio Garcia-Aguilar
87 papers · 25 as a fellow
José Guillem
75 papers · 29 as a resident
Jesse Smith
67 papers
JS
Jinru Shia
62 papers
AC
Andrea Cercek
53 papers
Emmanouil Pappou
51 papers
IW
Iris Wei
50 papers · 13 as a fellow
MW
Maria Widmar
48 papers · 5 as a fellow
LS
Leonard Saltz
38 papers
RY
Rona Yaeger
25 papers

Clinical trials

A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
Principal investigator · Recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2023–2028
ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis
Principal investigator · Active not recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2013–2026